The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure

BACKGROUND: Chronic oral anticancer therapies, are increasingly prescribed and present new challenges including the enhanced risk of overlooked drug-drug interactions (DDIs). Lengthy treatments and patients’ management by different professionals can lead to serious prescribing errors that therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagno, Sara, Buonadonna, Angela, Dalle Fratte, Chiara, Guardascione, Michela, Zanchetta, Martina, Posocco, Bianca, Orleni, Marco, Canil, Giovanni, Roncato, Rossana, Cecchin, Erika, Toffoli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624793/
https://www.ncbi.nlm.nih.gov/pubmed/37318715
http://dx.doi.org/10.1007/s40199-023-00465-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624793/
https://www.ncbi.nlm.nih.gov/pubmed/37318715
http://dx.doi.org/10.1007/s40199-023-00465-z

Ejemplares similares